Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 12, 1999, Pages 1647-1652

  Dani, R ^a,b   Queiroz, D M M ^a   Dias, M G M ^a   Franco, J M M ^a   Magalhaes L C R ^a   Mendes, G S ^a   Moreira, L S ^a   De Castro, L P F ^a   Toppa, N H ^a   Rocha, G A ^a   Cabral, M M D A ^a   Salles, P G O ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b R Estados Unidos 9 ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; FURAZOLIDONE; OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERSALIVATION; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; TASTE DISORDER; VOMITING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BRAZIL; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DUODENAL ULCER; ENDOSCOPY; FEMALE; FURAZOLIDONE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RANDOM ALLOCATION; TIME FACTORS;

EID: 0033405257     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00653.x     Document Type: Article

References (30)

1. Wilhelmensen I. Quality of life and Helicobacter pylori eradication. Scand J Gastroenterol 1996; 31(Suppl. 221): 18-20.
2. Coelho LG, Passos MC, Chausson Y, Castro LP. Five-day bismuth-free therapy for the eradication of Helicobacter pylori. Am J Gastroenterol 1991; 86: 971-5.
3. Queiroz DMM, Coimbra RS, Mendes EN, et al. Metronidazole-resistant Helicobacter pylori in a developing country. Am J Gastroenterol 1993; 88: 222-3.
4. Salazar M, Abalem I, Solari C, et al. Susceptibility of H. pylori to metronidazole in a Brazilian population. Mem Inst Oswaldo Cruz 1996; 91: 777-8.
5. Mégraud F. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori. Eur J Gastroenterol 1995; 7: 49-54.
6. Penston JG. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10: 469-86.
7. Lind T, Veldhuysen van Zanten SJ, Unge P. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two anti-microbials: the MACH-1 study. Helicobacter 1996; 1: 138-44.
8. Liu W, Lu B, Xiao S. Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection. Chung-Hua-Nei-Ko-Tsa-Chih 1996; 35: 803-6 (Chinese with abstract in English).
9. Queiroz DMM, Barbosa DVC, Magalhães PP, et al. Comparison of agar dilution method and E-test for metronidazole and clarithromycin resistance evaluation in Helicobacter pylori strains. In: Helicobacter Pylori: Basic Mechanisms to Clinical Cure. Hamilton, Ontario: Axcan Pharma, 1998: A26(Abstract).
10. Barbosa DVC. Estudo do perfil de susceptibilidade de amostras de Helicobacter pylori a antimicrobianos comumente empregados na erradicação da bactéria. MSc Thesis, Universidade Federal de Minas Gerais, Instituto de Cièncas Biológicas, Belo Horizonte, Brasil, 1998.
11. Queiroz DMM, Mendes EN, Rocha GA. An indicator medium for the isolation of Campylobacter pylori. J Clin Microbiol 1987; 25: 378-9.
12. Graham DY, de Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996; 91: 1072-6.
13. Wolle K, Nilius M, Leodolter WA, et al. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis 1998; 17: 519-21.
14. Misiewicz JJ. Harris AW, Bardhan KD. One-week triple therapy for Helicobacter pylori. A multicenter comparative trial. Gut 1997; 41: 735-9.
15. Vakil N, Halan B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol 1998; 93: 1432-5.
16. Altamirano A, Bondani A. Adverse reactions to furazolidone and other drugs. Scand J Gastroenterol 1989; 24(Suppl. 169): 70-80.
17. Goodwin CS, Blake P, Blincow G. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 1986; 17: 309-14.
18. Nagate T, Numata K, Hanada K, Kondo I. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics. J Clin Gastroenterol 1990; 27(Suppl. 1): S135-8.
19. De Boer WA, Haeck PWE, Otten MH, Mulcer CTJ. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between 7-day triple therapies and a 14-day dual therapy. Am J Gastroenterol 1998; 93: 1101-7.
20. Van der Wouden EJ, Thijs JC, van Zwet AA, et al. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. Am J Gastroenterol 1998; 93: 1228-31.
21. Zeng ZT, Wang ZY, Chu YX, et al. Double-blind short-term trial of furazolidone in peptic ulcer. Lancet 1985; i: 1048-9.
22. Zhao HY, Li G, Guo J, et al. Furazolidone in peptic ulcer. Lancet 1985; ii: 276-7.
23. Coelho LG, Passos MC, Queiroz DMM, et al. Furazolidone and cimetidine in patients with active duodenal ulcer and Helicobacter pylori in the gastric antrum. Arq Gastroenterol 1991; 28: 9-15.
24. Van Zwet AA, Thijs JC, Van der Wouden EJ, Kooy A. Low cure rate of Helicobacter pylori infection with omeprazole and furazolidone dual therapy for one week. Aliment Pharmacol Ther 1997; 11: 533-5.
25. Goodwin CS. Antimicrobial treatment of Helicobacter pylori infection. Clin Infect Dis 1997; 25; 1023-6.
26. Franco JMM, Castro FJ, Passos MCF, et al. Helicobacter pylori: erradicaçāo em curto prazo com esquema Belo Horizonte modificado. Gastroenterol Endosc Dig 1994; 13: 81-4.
27. Ramirez-Ramos A, Gilman RH, Leon-Barua R, et al. Rapid recurrence of Helicobacter pylori in Peruvian patients after successful eradication. Clin Infect Dis 1997; 25: 1027-31.
28. Segura AM, Gutierrez O, Otero W, et al. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11: 529-32.
29. de Koster E. Resistance of Helicobacter pylori to antibiotics. Res Clin Forums 1998: 20: 49-53.
30. Resende LM, Queiroz DMM, Barbosa AJA, et al. Histology of mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. Braz J Med Biol Res 1993; 26: 1279-89.